• 제목/요약/키워드: cyclosporin A

검색결과 185건 처리시간 0.024초

배지성분이 고정화 곰팡이 세포를 이용한 Cyclosporin A 생산에 미치는 영향 (Effect of Medium Components on the Production of Cyclosporin A by Immobilized Fungal Cell, Tolypocladium inflatum)

  • 이태호;장용근전계택
    • KSBB Journal
    • /
    • 제11권5호
    • /
    • pp.613-621
    • /
    • 1996
  • Wild-type 곰팡이인 Tolypoc/adium inflatum의 고정상배양을 통해 탄소원, 질소원, 아미노산 등이 peptide 항생제 계통 의 면역억제제인 cyclosporin A(CyA) 생합성에 미치는 영향을 조사하였다. 질소 원으로서 ammonium sulfate가 첨가된 경우에, f fructose 또는maltose 등을 탄소원으로 이용하는 배 지가 glucose가 첨가된 배지에 비해 월등히 높은 C CyA 생산성을 보였으나. ammonium sulfate의 부 재시에는 탄소원들의 종류에 관계없이 CyA 생산성 이 매우 낮게 나타났다. 질소원의 경우는 무기 질소 원인 ammonium sulfate가 CyA 생산에 가장 훌륭 한 성분으로 작용했으며, 그밖에 ammonium phos p phate, ammonium citrate 역시 CyA 생산을 어느 정도 증가시키는 효과를 보였다. 최척 ammonIum s sulfate의 농도는 109/L로 밝혀 졌으며 배양초기 에 a ammonium sulfate릎 첨가해 주는 경우가 배양중간 에 첨가하는 경우보다 CyA 생산에 더 효율적인 것 으로 나타났다. 아미노산의 경우 L-valine에 의한 C CyA 생합성 증진 효과가 가장 투렷하게 나타났다. 최적 L-valine 농도는 109/L이였으며 L-valine이 배양 초반부터 배지 중에 존재하는 것이 CyA 생합 성에 가장 유리한 것으로 나타났다.

  • PDF

Application of Factorial Experimental Designs for Optimization of Cyclosporin A Production by Tolypocladium inflatum in Submerged Culture

  • Abdel-Fattah, Y.R.;Enshasy, H. El;Anwar, M.;Omar, H.;Abolmagd, E.
    • Journal of Microbiology and Biotechnology
    • /
    • 제17권12호
    • /
    • pp.1930-1936
    • /
    • 2007
  • A sequential optimization strategy based on statistical experimental designs was employed to enhance the production of cyclosporin A (CyA) by Tolypocladium inflatum DSMZ 915 in a submerged culture. A 2-level Plackett-Burman design was used to screen the bioprocess parameters significantly influencing CyA production. Among the 11 variables tested, sucrose, ammonium sulfate, and soluble starch were selected, owing to their significant positive effect on CyA production. A response surface methodology (RSM) involving a 3-level Box-Behnken design was adopted to acquire the best process conditions. Thus, a polynomial model was created to correlate the relationship between the three variables and the CyA yield, and the optimal combination of the major media constituents for cyclosporin A production, evaluated using the nonlinear optimization algorithm of EXCEL-Solver, was as follows (g/l): sucrose, 20; starch, 20; and ammonium sulfate, 10. The predicted optimum CyA yield was 113 mg/l, which was 2-fold the amount obtained with the basal medium. Experimental verification of the predicted model resulted in a CyA yield of 110 mg/l, representing 97% of the theoretically calculated yield.

고정상 Tolypocladium inflatum균의 세포성장 지속성과 Cyclosporin A 생산성 향상 (Sustained Cell Growth and Improved Cyclosporin A Production Capablity of Immobilized Tolypocladium Inflatum Cells)

  • 전계택
    • KSBB Journal
    • /
    • 제9권2호
    • /
    • pp.200-210
    • /
    • 1994
  • Cyclosporin A(Cy A) 생산을 위한 회분식 생물 반응기 실험에서, 고정상세포를 이용함으로써 액상 배양과 비교할 때 생물공정 개선의 가능성이 있음을 제시하였다. 고농도 배지를 생산균주가 지수기 생장단계인 발효개시 후 139시간에 첨가하였을 때, 고정상배양과 액상배양 모두에서, 균주의 재활성 및 재생장으로 인해 CyA의 생산기간이 연장되어, 발효개시 후 250시간까지 최대 CyA 농도를 유지하였다. 반면에 배지의 첨가가 없는 단순 회분식 배양의 경우, 두 경우 모두 정체생장 단계에서 CyA의 생산성이 빠른 속도로 감소하였다. 주목할 점은 고정상 세포의 경우 CyA수율($Y_{p/x}$)이 고농도 배지를 첨가한 후에도 지수기때의 수율의 80%에 이르는 높은 값을 계속 유지할 수 있었으나, 이와는 대조적으로 액상 세포는 단지 58%만을 유지할 수 있었다. 그 결과 고정상배양의 최대 CyA생산성 이 액상배양과 비교하여 약 2배 정도 증가하였다.

  • PDF

Cyclosporin A가 in vitro에서 조골세포에 미치는 영향 (The Effect of Cyclosporin A on Osteoblast in vitro)

  • 김재우;이현정;강정화;옥승호;최봉규;유윤정;조규성;최성호
    • Journal of Periodontal and Implant Science
    • /
    • 제30권4호
    • /
    • pp.747-757
    • /
    • 2000
  • Cyclosporin A(CsA) is an immunosuppressive agent widely used for preventing graft rejecting response in organ transplantation. The basic properties of CsA to osteoblast has not been well known yet. A better understanding of the mechanisms of CsA function on bone could provide valuable information regarding basic properties of bone remodeling, pharmacotherapeutic intervention in metabolic bone disease, and the consequences of immunosuppression in bone physiology. The purpose of this study was to investigate the effect of CsA on osteoblast by evaluating parameters of proliferation, collagen synthetic activity, alkaline phosphatase activity, and ALP mRNA expression in mouse calvarial cell. 1. CsA ($3{\mu}g/m{\ell}$) treated mouse calvarial cell showed statistically significant increase in cell proliferation.(P<0.05) 2. CsA($1,\; 3{\mu}g/m{\ell}$) treated MC3T3 cell line showed statistically significant increase in cell proliferation. 3. The amount of collagen of CsA($3{\mu}g/m{\ell}$) treated mouse calvarial cell was decreased statistically significantly. 4. Alkaline phosphatase activity was increased statistically significantly in CsA treated group($1{\mu}g/m{\ell}$). 5. mRNA expression of ALP was increased in CsA treated group These results suggest that CsA could affect bone remodeling by modulating proliferation & differentiation of osteoblast.

  • PDF

다른 면역 억제제에 듣지 않는 국소성 분절성 사구체 경화증 환자에서 Cyclosporin A 2차 치료에 의한 완해 경험 (Second Trial of Cyclosporin A-Induced Remission in Other Immunosuppressant Therapy-Resistant FSGS Patient)

  • 조희연;이범희;강주형;하일수;정해일;최용
    • Childhood Kidney Diseases
    • /
    • 제9권1호
    • /
    • pp.83-90
    • /
    • 2005
  • Focal segmental glomerulosclerosis(FSGS) has been detected in approximately 10% of cases of Idiopathic nephrotic syndrome in children, and exhibits a poor response to initial steroid therapy, as well as a higher rate of progression to chronic renal failure and relapse after kidney transplantation. We describe a case of an eleven year-old boy with steroid-resistant FSGS who exhibited a response to a second trial of cyclosporin h(CsA) therapy. At the age of 26 months, this patient was diagnosed with steroid-resistant FSGS. For 9 years, he had undergone a gauntlet of therapies to induce remission; oral steroids, cyclophosphamide, methylprednisolone(mehyIPd) pulse therapy, CsA, and ibuprofen therapy. Although these therapies failed to induce remission, the patient's renal function remained In the normal range during the nine years of treatment. At the age of ten years, the patient's proteinuria decreased, and complete remission was attained with a second administration of CsA, coupled with a low dose of oral steroids. This patient continues to receive CsA without relapse. Therefore, our major concern involves the possibility of relapse after the discontinuation of CsA therapy Our findings in this case suggest that, in cases of refractory FSGS, if renal insufficiency does not emerge, aggressive therapy for the amelioration of proteinuria should be continuously pursued.

  • PDF

편측신절제 흰쥐에서 Cyclosporin A-유발 신독성에 대한 Verapamil의 효과 (Effects of Verapamil on Cyclosporin A-induced Nephrotoxicity in Uninephrectomized Rat)

  • 강주섭;고현철;이창호;신인철
    • Biomolecules & Therapeutics
    • /
    • 제6권2호
    • /
    • pp.130-138
    • /
    • 1998
  • In this study, the effect of verapamil (VER) on cyclosporin A (CsA)-induced nephrotoxicity was investigated in uninephrectomized rats. Male Wistar rats were administered CsA (50 mg/kg/day, p.o.) or VER (0.5 mg/kg/day, i.p.) with CsA (50 mg/kg/day, p.o.) for 20 days. The urinary N-acetyl-$\beta$-D-glucosaminidase (NAG) activity along with BUN, serum creatinine, creatinine clearance (CLcr), body weight, and 24 hr-urine output were measured and histopathologic changes of kidney were evaluated by light and electron microscopy. The results obtained from this study can be summarized as follows: While NAG activity, BUN and serum creatinine was progressively increased and CLcr significantly decreased in CsA group, VER almost signifi-cantly (p<0.05) suppressed and normalized CsA-induced changes in VER+CSA group. While urine output increased until 12th days and thereafter progressively decreased in CsA group, it gradually increased in control and VER+CSA group. While body weight progressively made a gain in control and VER+CSA groups, it significantly (p<0.05) lost in CsA group. On light microscopy, the glomerular hyperemia and proximal convoluted tubular (PCT) dilatation, focal tubular cell vacuolation and necrosis were clearly evident in CsA group, but, were not seen in other groups. Ultrastructural studies revealed thickened glomerular endothelium and basal lamina of capillary, irregular shaped pedicels of podocytes, indistinct slit pores and narrowed bowman's space. The large oval vacuoles with dense debris and phagosome were distributed in apical zone and deformed microvilli and mitochondria were seen in the PCT cell of CsA group. But, glomeruli and PCT cell were relatively preserved in normal apperance in other groups. In conclusion, it is suggested that verapamil has a protective effect on cyclosporine-induced nephrotoxicity in uninephrectomized rats.

  • PDF

Azithromycin이 Cyclosporin-A에 의한 치은섬유아세포 과증식에 미치는 영향에 대한 in vitro 연구 (The Effect of Azithromycin on the Cyclosporin-Ainduced Gingival Fibroblast Overgrowth)

  • 노현수;정원윤;최성호;조규성;박광균
    • Journal of Periodontal and Implant Science
    • /
    • 제33권4호
    • /
    • pp.643-650
    • /
    • 2003
  • Cyclosporin-A(CsA)는 장기와 조직 이식에 따른 거부반응을 조절하기 위해 사용되는 면역억제제로, 이식의학의 발달과 더불어 사용량이 증가하고 있다. CsA의 부작용중의 하나인 치은과증식은 30-50%의 빈도로 발발하고 있다. 최근 macrolide 계열의 항생제인 azithromycin을 이용하여 이런 부작용을 억제시킨다는 임상 보고가 있어서, 이를 실험적으로 확인하고자 하였다. 이를 위해 CsA를 투여한 적이 없는 환자에서 정상 치은조직을 채취, 치은섬유아세포를 배양하였다. 우선 CsA에 대한 치은섬유아세포의 반응을 보기 위해 다양한 농도($10^{-8}-10^{-10}$g/ml)로 처치하여, 세포 증식량과 교원질 합성량을 MTT assay와 Sirol Collagen Assay를 이용하여 측정하였다. 이에 반응을 보인 조건과 세포를 대상으로 다양한 농도($10^{-8}-10^{-10}$g/ml)의 azithromycin을 CsA와 동시 처치하여 아래와 같은 결과를 얻었다. 1. CsA는 일부 치은섬유모세포의 증식을 증가시켰다. 그러나 Collagen 합성능에는 변화를 주지 않았다. 2. Azithromycin은 정상 치은섬유아세포의 증식능에 영향을 미치지 않았다. 3. Azithromycin은 CsA 에 반응을 보인 세포의 증식을 감소시켰으며, 이는 정상 수준과 유사하였다. 이상의 결과에서 azithromycin이 CsA에 의한 치은과증식 치료에 유익하다고 사료된다.

Effect of Tripolyphosphate (TPP) on the Controlled Release of Cyclosporin A from Chitosan-coated Lipid Microparticles

  • Cheon, Ji-Woong;Shim, Chang-Koo;Chung, Suk-Jae;Kim, Dae-Duk
    • Journal of Pharmaceutical Investigation
    • /
    • 제39권1호
    • /
    • pp.59-63
    • /
    • 2009
  • Soybean phosphatidylcholine microparticles loaded with cyclosporin A (CsA) were prepared by the modified emulsion solvent diffusion and ionic gelation method, in which chitosan on the surface of the microparticles was crosslinked with various concentrations of tripolyphosphate (TPP). The morphology of the particles was characterized by scanning electron microscopy (SEM). The change of particle size and zeta-potential by chitosan on the surface of the lipid microparticles were systematically observed. The encapsulation efficiency and loading capacity of CsA in the particles were determined by high performance liquid chromatography (HPLC). In vitro release kinetics was studied using the dialysis method. In the results, the mean particle size and the zeta-potential of lipid microparticles increased when the attached chitosan was cross-linked (from 2.5 to 6.2 ${\mu}m$ and from -37.0 to +93.0 mV, respectively). The cyclosporin A-loaded lipid microparticles appeared discrete and spherical particles with smooth surfaces. The encapsulation efficiency of CsA was between 79% and 90% while the loading capacity was between 41% and 56%. In vitro release study showed that the crosslinkage of chitosan by TPP significantly delayed the release of CsA from the particles in a concentration-dependent manner. Thus, the release of CsA from the lipid microparticles could be controlled by tripolyphosphate used as a cross-linking agent.

Cyclosporin A Binding Protein Type-19 kDa Peptidyl-Prolyl Cis/Trans Isomerase from Euglena gracilis

  • SONG HYUK-HWAN;PARK SUNG-YONG;LEE CHAN
    • Journal of Microbiology and Biotechnology
    • /
    • 제15권5호
    • /
    • pp.1047-1053
    • /
    • 2005
  • Cyclosporin A binding protein type-19 kDa peptidyl-prolyl cis/trans isomerase (PPIases, EC 5.2.1.8) of Euglena gracilis was purified and some of its biochemical characters were elucidated. Purification of the PPIase was achieved by employing a series of steps involving ammonium sulfate precipitation, Superdex G-75 gel filtration chromatography, Mono­Q anion and Mono-S cation exchange chromatographies, and Superdex S-200 gel filtration chromatography on FPLC. Purified PPIase had a specific activity of 8,250 units/mg, showing a 27-fold increase compared with that of cell-free extract of Euglena gracilis. The enzyme consisted of a single polypeptide chain with a molecular mass of 19 kDa. It showed high substrate specificity to succinyl-Ala-Ala-Pro-Phe-p-nitroanilide, and $k_{car}/K_{m}$, for this substrate was found to be $61.19{\times}10^5/sec$. The isomer distributions were investigated at an equilibrium of seven different peptide substrates, varying Xaa in Suc-Ala-Xaa-Pro-Phe-p-nitroanilide in dimethylsulfoxide. The cis/trans equilibrium constants were estimated to be from 0.14 (Ile) to 0.63 (Gly), which correspond to $12.00\%\;to\;38.52\%$ of the cis population, respectively, under experimental condition. The enzyme was highly sensitive to the immunosuppressive ligand cyclosporin A, but not to other immunosuppressants such as FK506 and rapamycin. Thus, it appears to belong to the class of cyclophilin.

Acute Cyclosporin A-Treatment Impairs the Cytosolic Guanylate Cyclase-Mediated Vasodilatation in Rat Thoracic Aorta

  • Kook, Hyun
    • The Korean Journal of Physiology and Pharmacology
    • /
    • 제2권4호
    • /
    • pp.471-477
    • /
    • 1998
  • Cyclosporin A (CsA), a widely used immunosuppressant, is well known to cause nephrotoxicity and hypertension as major side effects. The present study was aimed at investigating the effects of CsA-pretreatment on the activities of cytosolic guanylate cyclase (cGC) in relation to the alteration of relaxant responses in the rat thoracic aorta. CsA $(10\;{\mu}M)-preincubation$ for 90 min significantly attenuated the vasodilatation induced by sodium nitroprusside (SNP), a cytosolic guanylate cyclase activator, shifting the dose-response curve to the right. The increase in cGMP contents induced by SNP was markedly attenuated by CsA. SNP ($1\;{\mu}M{\sim}\;mM$) increased the cGC activity dose-dependently, and the increase was completely abolished by CsA. CsA attenuated the SNP-induced cGC activation dose-dependently. The abolishing effect of CsA-pretreatment on the SNP-induced cGC activation was not affected by washing the preparation, suggesting that the inhibition is irreversible. When CsA was added simultaneously with SNP, cGC activation was not attenuated. 1-(5-isoquinolinylsulfonyl)-2-methyl piperazine (H-7), a protein kinase C (PKC) inhibitor, decreased SNP-induced cGC activation and blocked the CsA-attenuation of cGC activation. These results suggest that CsA directly inhibits cGC participating in the CsA-induced impairment of vasodilatation, and that PKC is involved in the inhibitory action of CsA on cGC.

  • PDF